TABLE 4.
Network Meta-analysis results of serum creatinine levels in stem cell groups at 7 days after administration.
| ADMSCs | 0.11 (0.00 to 0.47) | -0.03 (-0.18 to 0.51) | 0.39 (0.16 to 0.62) | 0.33 (0.10 to 0.51) | -0.04 (-0.27 to 0.39) | 0.40 (0.13 to 0.63) | 0.34 (0.16 to 0.58) |
|---|---|---|---|---|---|---|---|
| −0.11 (−0.47 to −0.00) | EPCs | −0.14 (−0.18 to 0.04) | 0.20 (0.14 to 0.33) | 0.14 (0.04 to 0.27) | −0.16 (−0.51 to 0.18) | 0.22 (0.13 to 0.30) | 0.17 (0.11 to 0.27) |
| 0.03 (−0.51 to 0.18) | 0.14 (−0.04 to 0.18) | MDMSCs | 0.35 (0.10 to 0.48) | 0.29 (0.00 to 0.42) | −0.01 (−0.55 to 0.33) | 0.37 (0.12 to 0.43) | 0.32 (0.07 to 0.42) |
| −0.39 (−0.62 to −0.16) | −0.20 (−0.33 to −0.14) | −0.35 (−0.48 to −0.10) | Placebo | −0.06 (−0.10 to −0.05) | −0.36 (−0.66 to −0.15) | −0.01 (−0.05 to 0.06) | −0.04 (−0.06 to 0.00) |
| −0.33 (−0.51 to −0.10) | −0.14 (−0.27 to −0.04) | −0.29 (−0.42 to −0.00) | 0.06 (0.05 to 0.10) | RPCs | −0.30 (−0.55 to −0.10) | 0.07 (0.00 to 0.12) | 0.03 (−0.01 to 0.07) |
| 0.04 (−0.39 to 0.27) | 0.16 (−0.18 to 0.51) | 0.01 (−0.33 to 0.55) | 0.36 (0.15 to 0.66) | 0.30 (0.10 to 0.55) | SHED | 0.37 (0.10 to 0.67) | 0.33 (0.09 to 0.62) |
| −0.40 (−0.63 to −0.13) | −0.22 (−0.30 to −0.13) | −0.37 (−0.43 to −0.12) | 0.01 (−0.06 to 0.05) | −0.07 (−0.12 to −0.00) | −0.37 (−0.67 to −0.10) | UCMSCs | −0.03 (−0.11 to 0.03) |
| −0.34 (−0.58 to −0.16) | −0.17 (−0.27 to −0.11) | −0.32 (−0.42 to −0.07) | 0.04 (−0.00 to 0.06) | −0.03 (−0.07 to 0.01) | −0.33 (−0.62 to −0.09) | 0.03 (−0.03 to 0.11) | USCs |